What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?
- PMID: 23674753
- PMCID: PMC3716158
- DOI: 10.1128/AAC.00189-13
What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?
Comment in
-
Reply to "What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?".Antimicrob Agents Chemother. 2013 Jun;57(6):2906. doi: 10.1128/AAC.00592-13. Antimicrob Agents Chemother. 2013. PMID: 23674754 Free PMC article. No abstract available.
Comment on
-
Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.Antimicrob Agents Chemother. 2012 Nov;56(11):5503-10. doi: 10.1128/AAC.00802-12. Epub 2012 Aug 13. Antimicrob Agents Chemother. 2012. PMID: 22890761 Free PMC article.
References
-
- Ascioglu S, Rex RH, de Pauw B, Bennet JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7–14 - PubMed
-
- De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Mashmeyer G, Bille J, Dismukes DE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennet JE. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813–1821 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
